Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice.
CONCLUSION: This work emphasizes the interest of a well-thought-out interpretation of CSF biomarkers in neurological diseases, particularly in the case of high Tau protein concentrations in the CSF.
PMID: 31051163 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Lehmann S, Paquet C, Malaplate-Armand C, Magnin E, Schraen S, Quillard-Muraine M, Bousiges O, Delaby C, Dumurgier J, Hugon J, Sablonnière B, Blanc F, Wallon D, Gabelle A, Laplanche JL, Bouaziz-Amar E, Peoc'h K, ePLM Group Tags: Clin Chim Acta Source Type: research
More News: Alzheimer's | Biology | Brain | Chemistry | Dementia | Laboratory Medicine | Neurology | Paraneoplastic Syndrome | Study